Health Insurance Innovations Received its Third Buy in a Row


After Cantor Fitzgerald and Lake Street gave Health Insurance Innovations (NASDAQ: HIIQ) a Buy rating last month, the company received another Buy, this time from Canaccord Genuity. Analyst Richard Close assigned a Buy rating to Health Insurance Innovations yesterday and set a price target of $55. The company’s shares opened today at $30.50.

Close observed:

“We provided a timeline here that showed the comment period ending 4/23/18. Once the rule is finalized it would go into effect 60 days later.”

According to TipRanks.com, Close is a 5-star analyst with an average return of 12.4% and a 60.1% success rate. Close covers the Services sector, focusing on stocks such as Envision Healthcare, Evolent Health, and Premier Inc.

Health Insurance Innovations has an analyst consensus of Strong Buy, with a price target consensus of $48.14.

See today’s analyst top recommended stocks >>

Health Insurance Innovations’ market cap is currently $382.9M and has a P/E ratio of 23.83. The company has a Price to Book ratio of 4.19.

Based on the recent corporate insider activity of 58 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HIIQ in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Health Insurance Innovations, Inc. is a developer, distributor and virtual administrator of affordable individual and family health insurance plans and supplemental products. The company sells individual and family insurance plans that include short-term medical insurance plans and hospital indemnity plans.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts